The Bulletin from the Clinical Pharmacist

VOL: 2 ISSUE: 10 DATE: Nov 24
Author: Hasna Raihanath, Clinical Pharmacist, Kauvery, Hospital, Marathahalli
  • The information below is an example of AMR that depletes the “pool of effective antibiotics” available to treat bacterial infections.
  • Inappropriate use of antibiotics occurs when they are used inappropriately, either by being overprescribed, underused, or taken incorrectly. This can contribute to the development of antimicrobial resistance (AMR), a global health threat.
  • A blood culture from one of a patient isolated a gram negative bacteria, Enterobacter Cloacae. The antibiotic susceptibility profile shows a worrying pattern. Susceptibility reports shows:                                                                       
    • Resistant to: Amoxicillin +Clavulanic acid, Amikacin, Cefepime,
    • Ciprofloxacin, Co-trimoxazole, Ceftriaxone, Gentamicin, Piperacillin-tazobactam.
    • Intermediate to: Cefoperazone/Sulbactam, Colistin.
  • Susceptible to: Imipenem, Meropenem.

Discussion

  • The above report shows that only two antibiotics, Imipenem and Meropenem, are effective and are the last -line antibiotics available in case of severe MDR infection.
  • This report highlights the extent of AMR in the community consequent of the inappropriate use and use of antibiotics, and leaving us with no further options for treatment.
  • Inappropriate use of antibiotics has led to bacteria developing resistance at an alarming rate, faster than new drugs being developed, and made available for treatment, in the market
  • It is a high time that we take all necessary steps to prevent antibiotic resistance. A few steps are:
  • Putting a complete ban on selling the antibiotics Over-the Counter.
  • Prescribing antibiotics based only on culture and sensitivity reports.
  • Limiting the use of high- end antibiotics initially.
  • Avoiding the use of antibiotics for viral infections
  • Educating the people to complete the course of antibiotics.
Kauvery Hospital